Regulation of the erythropoietin gene.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 8318914)

Published in Stem Cells on May 01, 1993

Authors

K L Blanchard1, J Fandrey, M A Goldberg, H F Bunn

Author Affiliations

1: Division of Hematology/Oncology, Brigham and Women's Hospital, Boston, MA 02115.

Articles by these authors

Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci U S A (1990) 10.01

Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A (1998) 9.56

Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science (1988) 5.71

Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci U S A (1996) 5.69

Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem (1995) 5.20

Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem (1996) 5.15

An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci U S A (1996) 4.57

The glycosylation of hemoglobin: relevance to diabetes mellitus. Science (1978) 3.87

Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem (1996) 3.80

Comprehensive health care reform and managed competition. N Engl J Med (1992) 3.44

Exchange of heme among hemoglobins and between hemoglobin and albumin. J Biol Chem (1968) 3.09

The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo. J Clin Invest (1976) 3.00

Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus. J Clin Endocrinol Metab (1977) 2.84

The regulated expression of erythropoietin by two human hepatoma cell lines. Proc Natl Acad Sci U S A (1987) 2.51

Further identification of the nature and linkage of the carbohydrate in hemoglobin A1c. Biochem Biophys Res Commun (1975) 2.46

Erythropoietin mRNA levels are governed by both the rate of gene transcription and posttranscriptional events. Blood (1991) 2.41

Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood (1999) 2.35

Continuous subcutaenous administration of deferoxamine in patients with iron overload. N Engl J Med (1977) 2.31

Expression of the human c-fms proto-oncogene in hematopoietic cells and its deletion in the 5q- syndrome. Cell (1985) 2.28

Regulation of the erythropoietin gene. Blood (1999) 2.10

Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction. Proc Natl Acad Sci U S A (1991) 1.95

Hypoxic induction of the human erythropoietin gene: cooperation between the promoter and enhancer, each of which contains steroid receptor response elements. Mol Cell Biol (1992) 1.94

Exchange of heme among hemoglobin molecules. Proc Natl Acad Sci U S A (1966) 1.81

The interaction of 2,3-diphosphoglycerate with various human hemoglobins. J Clin Invest (1970) 1.81

Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J Biol Chem (1984) 1.80

Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein. Mol Cell Biol (1998) 1.80

Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res (1995) 1.75

Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor. Circulation (2000) 1.70

Organic cation transport in the rat kidney in vivo visualized by time-resolved two-photon microscopy. Kidney Int (2007) 1.68

Regulation of erythrocyte cation and water content in sickle cell anemia. Science (1986) 1.65

Evaluation of glycosylated hemoglobin diabetic patients. Diabetes (1981) 1.65

Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: iron-deficient erythropoiesis in iron-replete subjects. Blood (1993) 1.62

Neuropsychological correlates of white-matter lesions in healthy elderly subjects. A threshold effect. Arch Neurol (1992) 1.59

Sites of nonenzymatic glycosylation of human hemoglobin A. J Biol Chem (1980) 1.56

Accumulation of HIF-1alpha under the influence of nitric oxide. Blood (2001) 1.55

A study of induced hyponatremia in the prevention and treatment of sickle-cell crisis. N Engl J Med (1980) 1.54

Efficacy of CT in distinguishing small-bowel obstruction from other causes of small-bowel dilatation. AJR Am J Roentgenol (1994) 1.51

Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood (1992) 1.51

The orphan receptor hepatic nuclear factor 4 functions as a transcriptional activator for tissue-specific and hypoxia-specific erythropoietin gene expression and is antagonized by EAR3/COUP-TF1. Mol Cell Biol (1995) 1.50

Kinetic analysis of the nonenzymatic glycosylation of hemoglobin. J Biol Chem (1981) 1.50

Treatment of sickle cell anemia with hydroxyurea and erythropoietin. N Engl J Med (1990) 1.47

Nonenzymatic glycosylation of erythrocyte membrane proteins. Relevance to diabetes. J Clin Invest (1980) 1.47

Cotranslational amino-terminal processing of cytosolic proteins. Cell-free expression of site-directed mutants of human hemoglobin. J Biol Chem (1988) 1.46

Oxygen supply and oxygen-dependent gene expression in differentiating embryonic stem cells. Proc Natl Acad Sci U S A (1996) 1.46

Regulation of vascular endothelial growth factor expression by insulin-like growth factor I. Diabetes (1997) 1.45

Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein. J Biol Chem (1996) 1.43

Educating the biomedical scientist. FASEB J (1995) 1.43

Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response. Am J Med (1994) 1.43

The separation of human and animal hemoglobins by isoelectric focusing in polyacrylamide gel. Biochim Biophys Acta (1971) 1.42

In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reaction. Blood (1993) 1.41

Erythropoietin production and pH. Lancet (1992) 1.40

Modulators of protein kinase C inhibit hypoxia-induced erythropoietin production. Exp Hematol (1993) 1.40

Identification of a cytochrome b-type NAD(P)H oxidoreductase ubiquitously expressed in human cells. Proc Natl Acad Sci U S A (1999) 1.39

The renal handling of hemoglobin. I. Glomerular filtration. J Exp Med (1969) 1.38

Glycosylation of hemoglobin in vitro: affinity labeling of hemoglobin by glucose-6-phosphate. Proc Natl Acad Sci U S A (1976) 1.38

Amino-terminal processing of proteins: hemoglobin South Florida, a variant with retention of initiator methionine and N alpha-acetylation. Proc Natl Acad Sci U S A (1985) 1.37

Hepatic hemangiomas and malignant tumors: improved differentiation with heavily T2-weighted conventional spin-echo MR imaging. Radiology (1994) 1.37

Differences in the interaction of 2,3-diphosphoglycerate with certain mammalian hemoglobins. Science (1971) 1.36

Nonenzymatic glycosylation of protein: relevance to diabetes. Am J Med (1981) 1.34

Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med (1981) 1.33

Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling. J Biol Chem (1999) 1.33

Molecular and cellular pathogenesis of hemoglobin SC disease. Proc Natl Acad Sci U S A (1982) 1.32

Electrostatic attraction governs the dimer assembly of human hemoglobin. J Biol Chem (1986) 1.31

Structural heterogeneity of human hemoglobin A due to nonenzymatic glycosylation. J Biol Chem (1979) 1.30

Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood (1986) 1.30

Characterization of glycosylated hemoglobins. Relevance to monitoring of diabetic control and analysis of other proteins. J Clin Invest (1983) 1.29

Signal transduction. How do cells sense oxygen? Science (2001) 1.27

Pericellular PO2 and O2 consumption in monolayer cell cultures. Respir Physiol (1995) 1.27

The interaction between erythrocyte organic phosphates, magnesium ion, and hemoglobin. J Biol Chem (1971) 1.26

Subunit assembly of hemoglobin: an important determinant of hematologic phenotype. Blood (1987) 1.25

Hemoglobin function in stored blood. J Clin Invest (1969) 1.25

Regulation of cation content and cell volume in hemoglobin erythrocytes from patients with homozygous hemoglobin C disease. J Clin Invest (1985) 1.22

Erythropoietin structure-function relationships. Mutant proteins that test a model of tertiary structure. J Biol Chem (1993) 1.21

Erythropoietin mRNA expression in human fetal and neonatal tissue. Blood (1998) 1.21

Hypoxia and interleukin-1beta stimulate vascular endothelial growth factor production in human proximal tubular cells. Kidney Int (2000) 1.20

Interleukin 1 beta and tumour necrosis factor alpha induce a macrophage-type of nitric oxide synthase in rat renal mesangial cells. Eur J Biochem (1992) 1.20

Glycosylated minor components of human adult hemoglobin. Purification, identification, and partial structural analysis. J Biol Chem (1978) 1.20

A rapid method for the determination of glycosylated hemoglobins using high pressure liquid chromatography. Metabolism (1978) 1.20

Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin. Blood (2001) 1.19

The value of the peripheral blood smear in anemic inpatients. The laboratory's reading v a physician's reading. Arch Intern Med (1983) 1.18

Functional properties of hemoglobin Kempsey. J Biol Chem (1974) 1.18

Spontaneous radiographic disappearance of cerebral cysticercosis: three cases. Neurology (1983) 1.18

Participation of hemoglobins A and F in polymerization of sickle hemoglobin. J Biol Chem (1977) 1.15

Enzyme-linked immunosorbent assay for the diagnosis of cerebral cysticercosis. J Clin Microbiol (1984) 1.15

Glycosylated hemoglobin in human and animal red cells. Role of glucose permeability. Diabetes (1982) 1.14

Erythropoietin structure-function relationships. Identification of functionally important domains. J Biol Chem (1994) 1.14

Identification and characterization of a low oxygen response element involved in the hypoxic induction of a family of Saccharomyces cerevisiae genes. Implications for the conservation of oxygen sensing in eukaryotes. J Biol Chem (2001) 1.11

Effects of transition metals on the expression of the erythropoietin gene: further evidence that the oxygen sensor is a heme protein. Biochem Biophys Res Commun (1996) 1.11

The validity of hysterical signs and symptoms. J Nerv Ment Dis (1986) 1.10

Hemoglobin Cranston, an unstable variant having an elongated beta chain due to nonhomologous crossover between two normal beta chain genes. Proc Natl Acad Sci U S A (1975) 1.10

The separation of partially oxidized hemoglobins. Biochim Biophys Acta (1971) 1.09

Hypoxia up-regulates the activity of a novel erythropoietin mRNA binding protein. J Biol Chem (1991) 1.08

A quantitative MRI study of vascular dementia. Neurology (1992) 1.08

Oxygen sensing and signaling: impact on the regulation of physiologically important genes. Respir Physiol (1999) 1.07

ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia. Leukemia (2003) 1.06

Erythropoietin structure-function relationships: high degree of sequence homology among mammals. Blood (1993) 1.05